Skip to main content
. 2017 May 25;6:22–30. doi: 10.1016/j.omto.2017.05.005

Figure 6.

Figure 6

Cyclophosphamide Enhances rRp450-Mediated Survival in a Mouse Model of AT/RT

Kaplan-Meier survival analysis of mice implanted with BT-12 AT/RT cells treated 7 days later with 5 × 105 PFUs of rRp450. Cyclophosphamide (CPA), 2 mg dose, was administered 24 and 48 hr following virus treatment.